tocilizumab
Marketedupdated 2mo agoby Genentech Inc
Approvedcommunity read0 votes
indications
investigational
Rheumatoid Arthritis
all catalysts(61)
approval · 60
Jan 8, 2010
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jan 4, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 15, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 15, 2011
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 20, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 13, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 11, 2012
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 29, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jul 2, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 21, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 21, 2013
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Nov 13, 2014
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 18, 2015
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
phase 1 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that